Home Antibody All anti-BCL2L1 antibodies
Anti-BCL2L1 PHOSPHO Antibody
Also for BCL2L1 (NM_001191)
|The antiserum was produced against synthesized phosphopeptide derived from human BCL-XL around the phosphorylation site of threonine 47 (M-E-TP-P-S).|
|Human, Mouse, Rat
|WB, IHC, IF
||WB: 1:500~1:3000, IHC: 1:50~1:100, IF: 1:100~1:500, ELISA: 1:40000
|Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.|
|The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. (Protein A or G Sepharose)
|BCL-XL (Phospho-Thr47) antibody detects endogenous levels of BCL-XL only when phosphorylated at threonine 47.
|Homo sapiens BCL2-like 1 (BCL2L1), transcript variant 2|
|Bcl-X; bcl-xL; BCL-XL/S; bcl-xS; BCL2L; BCLX; BCLXL; BCLXS; PPP1R52|
Jak-STAT signaling pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of extracts from 293 cells, treated with UV (30mins), using BCL-XL (Phospho-Thr47) antibody.The lane on the right is treated with the synthesized peptide.
Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue, using BCL-XL (Phospho-Thr47) antibody.The picture on the right is treated with the synthesized peptide.
Immunofluorescence analysis of NIH/3T3 cells, using BCL-XL (Phospho-Thr47) antibody.The picture on the right is treated with the synthesized peptide.